Geburtshilfe. Schwangerenvorsorge im Umbau: Vom Kopf auf die Füße?

Die klassische Schwangerenvorsorge in Deutschland, sowie in den meisten westlichen Ländern, zeigt in ihrer Untersuchungsfrequenz eine pyramidenartige Struktur. Sind anfangs nur wenige Untersuchungstermine in der Schwangerschaft vorgesehen, nimmt die Häufigkeit der Kontrollen mit zunehmendem Gestationsalter zu. Seit einigen Jahren lassen sich immer mehr Risiken für verschiedene Schwangerschaftskomplikationen im Ersttrimester-Screening vorhersagen. Ist es an der Zeit, die „Pyramide der Schwangerenvorsorge“ umzudrehen?

• Literatur

• 1 Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeksʼ assessment. Prenat Diagn 2011; 31: 3-6
• 2 Nicolaides KH, Azar G, Byrne D et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869
• 3 Akolekar R, Syngelaki A, Sarquis R et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011; 31: 66-74
• 4 Greco E, Lange A, Ushakov F et al. Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn 2010; 31: 84-89
• 5 Syngelaki A, Chelemen T, Dagklis T et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 2011; 31: 90-102
• 6 Bujold E, Roberge S, Lacasse Y et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116 (2 Pt 1) 402-414
• 7 Kagan KO, Hoopmann M, Abele H et al. Future developments in obstetrics. Gynäkologe 2012; 45: 684-689
• 8 Yu CKH, Khouri O, Onwudiwe N et al. for the Fetal Medicine Foundation Second-Trimester Screening Group. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31: 310-313
• 9 MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533-538
• 10 Papageorghiou AT, Campbell S. First trimester screening for preeclampsia. Curr Opin Obstet Gynecol 2006; 18: 594-600
• 11 Meads CA, Cnossen JS, Meher S et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008; 12: iii-iv 1–270
• 12 Cuckle HS. Screening for pre-eclampsia–lessons from aneuploidy screening. Placenta 2011; 32 (Suppl.) S42-S48
• 13 Honest H, Forbes CA, Durée KH et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009; 13: 1-627
• 14 Celik E, To M, Gajewska K et al. on behalf of the Fetal Medicine Foundation Second Trimester Screening Group. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 2008; 31: 549-554
• 15 Vergnes J, Sixou M. Preterm low birth weight and maternal periodontal status: a meta-analysis. Am J Obstet Gynecol 2007; 196: 135.e1-135.e7
• 16 Fonseca EB, Celik E, Parra M et al. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-469
• 17 Goya M, Pratcorona L, Merced C et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012; 379 (9828) 1800-1806
• 18 Metzger BE, Lowe LP, Dyer AR et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
• 19 Nanda S, Akolekar R, Sarquis R et al. Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia. Prenat Diagn 2011; 31: 479-483
• 20 Plasencia W, Garcia R, Pereira S et al. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther 2011; 30: 108-115
• 21 Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome?. Ultrasound Obstet Gynecol 2005; 25: 258-264
• 22 Karagiannis G, Akolekar R, Sarquis R et al. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011; 29: 148-154
• 23 Plasencia W, González Dávila E, Tetilla V et al. First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol 2012; 39: 389-395
• 24 Kagan KO, Etchegaray A, Zhou Y et al. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34: 14-18
• 25 Kagan KO, Wright D, Valencia C et al. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free-hCG and pregnancy-associated plasma protein-A. Human Reproduction 2008; 23: 1968-1975
• 26 Kagan KO, Hoopmann M, Kozlowski P. Assessment of foetal DNA in maternal blood – a useful tool in the hands of prenatal specialists. Geburtsh Frauenheilk 2012; 72: 998-1003
• 27 Nicolaides KH, Syngelaki A, Ashoor G et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e1-374.e6
• 28 Pereira S, Ganapathy R, Syngelaki A et al. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 2011; 117: 1384-1391
• 29 Scheier M, Lachmann R, Pětroš M et al. Three-dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11–13 weeksʼ gestation. Ultrasound Obstet Gynecol 2011; 38: 625-629
• 30 Chaoui R, Nicolaides KH. Detecting open spina bifida at the 11–13-week scan by assessing intracranial translucency and the posterior brain region: mid-sagittal or axial plane?. Ultrasound Obstet Gynecol 2011; 38: 609-612
• 31 Chaoui R, Benoit B, Heling KS et al. Prospective detection of open spina bifida at 11–13 weeks by assessing intracranial translucency and posterior brain. Ultrasound Obstet Gynecol 2011; 38: 722-726
• 32 Bartlett LA, Berg CJ, Shulman HB et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-737